239 related articles for article (PubMed ID: 25332170)
1. Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.
Dammer EB; Lee AK; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
Proteomics; 2015 Jan; 15(2-3):508-519. PubMed ID: 25332170
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.
Rudrabhatla P; Jaffe H; Pant HC
FASEB J; 2011 Nov; 25(11):3896-905. PubMed ID: 21828286
[TBL] [Abstract][Full Text] [Related]
3. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
[TBL] [Abstract][Full Text] [Related]
4. Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome.
Tan H; Wu Z; Wang H; Bai B; Li Y; Wang X; Zhai B; Beach TG; Peng J
Proteomics; 2015 Jan; 15(2-3):500-7. PubMed ID: 25307156
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated tau interactome in the human Alzheimer's disease brain.
Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.
Sathe G; Mangalaparthi KK; Jain A; Darrow J; Troncoso J; Albert M; Moghekar A; Pandey A
OMICS; 2020 Apr; 24(4):216-227. PubMed ID: 32182160
[TBL] [Abstract][Full Text] [Related]
7. Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.
Herskowitz JH; Seyfried NT; Duong DM; Xia Q; Rees HD; Gearing M; Peng J; Lah JJ; Levey AI
J Proteome Res; 2010 Dec; 9(12):6368-79. PubMed ID: 20886841
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.
Hoos MD; Richardson BM; Foster MW; Everhart A; Thompson JW; Moseley MA; Colton CA
J Proteome Res; 2013 Oct; 12(10):4462-77. PubMed ID: 24006891
[TBL] [Abstract][Full Text] [Related]
9. Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry.
Xia Q; Cheng D; Duong DM; Gearing M; Lah JJ; Levey AI; Peng J
J Proteome Res; 2008 Jul; 7(7):2845-51. PubMed ID: 18510355
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
Yang SD; Yu JS; Shiah SG; Huang JJ
J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
12. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.
Abreha MH; Dammer EB; Ping L; Zhang T; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
Proteomics; 2018 Oct; 18(20):e1800108. PubMed ID: 30230243
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
Chen M; Xia W
J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
[TBL] [Abstract][Full Text] [Related]
15. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
16. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.
Liu WK; Moore WT; Williams RT; Hall FL; Yen SH
J Neurosci Res; 1993 Feb; 34(3):371-6. PubMed ID: 8455212
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.
Donovan LE; Higginbotham L; Dammer EB; Gearing M; Rees HD; Xia Q; Duong DM; Seyfried NT; Lah JJ; Levey AI
Proteomics Clin Appl; 2012 Apr; 6(3-4):201-11. PubMed ID: 22532456
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
19. Ethylenediaminetetraacetic acid increases identification rate of phosphoproteomics in real biological samples.
Nakamura T; Myint KT; Oda Y
J Proteome Res; 2010 Mar; 9(3):1385-91. PubMed ID: 20099890
[TBL] [Abstract][Full Text] [Related]
20. Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro.
Mendoza J; Sekiya M; Taniguchi T; Iijima KM; Wang R; Ando K
J Proteome Res; 2013 Jun; 12(6):2654-65. PubMed ID: 23550703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
